Attana has obtained CE-IVD Marking for its first products within clinical diagnostics
Attana has today registered the AVA™ SARS-CoV-2 IgG Immunoassay and the analytical instrument Attana Cell™ 250 for CE-IVD Marking with the Swedish Medical Products Agency (“Läkemedelsverket”). The test and the instrument meet all applicable requirements for CE-IVD Marking, which allows Attana to start marketing and selling the products to clinical laboratories within the EU.Attana’s CE-IVD Marked productsThe CE-IVD Marked test is a serological immunoassay for the detection of SARS-CoV-2 IgG antibodies and is used with Attana's analytical instruments. The CE-IVD Marking initially includes